
TY  - JOUR
TI  - 9TH ECE PROCEEDINGS
JO  - Epilepsia
VL  - 51
IS  - s4
SN  - 0013-9580
UR  - https://doi.org/10.1111/j.1528-1167.2010.02658.x
DO  - doi:10.1111/j.1528-1167.2010.02658.x
SP  - 1
EP  - 189
PY  - 2010
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Vox Sanguinis
JA  - Vox Sang
VL  - 105
IS  - s1
SN  - 0042-9007
UR  - https://doi.org/10.1111/vox.12047
DO  - doi:10.1111/vox.12047
SP  - 1
EP  - 64
PY  - 2013
ER  - 

TY  - JOUR
TI  - Published Only
JO  - Journal of Digestive Diseases
JA  - Journal of Digestive Diseases
VL  - 15
IS  - S1
SN  - 1751-2972
UR  - https://doi.org/10.1111/1751-2980.12194
DO  - doi:10.1111/1751-2980.12194
SP  - 29
EP  - 173
PY  - 2014
ER  - 

TY  - JOUR
TI  - Program: First joint meeting of the American society for bone and mineral research and the international conferences on calcium regulating hormones
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 4
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650040702
DO  - doi:10.1002/jbmr.5650040702
SP  - 1
EP  - 419
PY  - 1989
ER  - 

TY  - JOUR
TI  - Abstracts of the 6th Annual Meeting of the French Pharmacological Society   Joint Meeting with Pharmacological Societies of Brazil and Portugual
JO  - Fundamental & Clinical Pharmacology
VL  - 16
IS  - 5
SN  - 0767-3981
UR  - https://doi.org/10.1046/j.1472-8206.2002.00128.x
DO  - doi:10.1046/j.1472-8206.2002.00128.x
SP  - 369
EP  - 439
PY  - 2002
ER  - 

TY  - JOUR
AU  - Wang, Xue
AU  - Shen, Shichen
AU  - Rasam, Sailee Suryakant
AU  - Qu, Jun
TI  - MS1 ion current-based quantitative proteomics: A promising solution for reliable analysis of large biological cohorts
JO  - Mass Spectrometry Reviews
JA  - Mass Spec Rev
VL  - 38
IS  - 6
SN  - 0277-7037
UR  - https://doi.org/10.1002/mas.21595
DO  - doi:10.1002/mas.21595
SP  - 461
EP  - 482
KW  - MS1 quantification
KW  - ion current-based proteomics
KW  - LC-MS
KW  - reproducible protein measurement
KW  - large cohorts
PY  - 2019
AB  - The rapidly-advancing field of pharmaceutical and clinical research calls for systematic, molecular-level characterization of complex biological systems. To this end, quantitative proteomics represents a powerful tool but an optimal solution for reliable large-cohort proteomics analysis, as frequently involved in pharmaceutical/clinical investigations, is urgently needed. Large-cohort analysis remains challenging owing to the deteriorating quantitative quality and snowballing missing data and false-positive discovery of altered proteins when sample size increases. MS1 ion current-based methods, which have become an important class of label-free quantification techniques during the past decade, show considerable potential to achieve reproducible protein measurements in large cohorts with high quantitative accuracy/precision. Nonetheless, in order to fully unleash this potential, several critical prerequisites should be met. Here we provide an overview of the rationale of MS1-based strategies and then important considerations for experimental and data processing techniques, with the emphasis on (i) efficient and reproducible sample preparation and LC separation; (ii) sensitive, selective and high-resolution MS detection; iii)accurate chromatographic alignment; (iv) sensitive and selective generation of quantitative features; and (v) optimal post-feature-generation data quality control. Prominent technical developments in these aspects are discussed. Finally, we reviewed applications of MS1-based strategy in disease mechanism studies, biomarker discovery, and pharmaceutical investigations.
ER  - 

TY  - JOUR
TI  - Poster Session 1, Sunday 13 September
JO  - European Journal of Neurology
VL  - 16
IS  - s3
SN  - 1351-5101
UR  - https://doi.org/10.1111/j.1468-1331.2009.02821.x
DO  - doi:10.1111/j.1468-1331.2009.02821.x
SP  - 55
EP  - 334
PY  - 2009
ER  - 

TY  - JOUR
AU  - Krämer, Stefanie D.
AU  - Testa, Bernard
TI  - The Biochemistry of Drug Metabolism – An Introduction
JO  - Chemistry & Biodiversity
JA  - Chemistry & Biodiversity
VL  - 6
IS  - 10
SN  - 1612-1872
UR  - https://doi.org/10.1002/cbdv.200900233
DO  - doi:10.1002/cbdv.200900233
SP  - 1477
EP  - 1660
KW  - Drug metabolism
KW  - Enzyme induction
KW  - Enzyme inhibition
KW  - Nuclear receptors
KW  - Ontogeny
PY  - 2009
AB  - Abstract This review on intra-individual factors affecting drug metabolism completes our series on the biochemistry of drug metabolism. The article presents the molecular mechanisms causing intra-individual differences in enzyme expression and activity. They include enzyme induction by transcriptional activation and enzyme inhibition on the protein level. The influencing factors are of physiological, pathological, or external origin. Tissue characteristics and developmental age strongly influence enzyme-expression patterns. Further influencing factors are pregnancy, disease, or biological rhythms. Xenobiotics, drugs, constituents of herbal remedies, food constituents, ethanol, and tobacco can all influence enzyme expression or activity and, hence, affect drug metabolism.
ER  - 

TY  - JOUR
TI  - Poster Tours and Posters on Display
JO  - Pediatric Diabetes
JA  - Pediatr Diabetes
VL  - 20
IS  - S28
SN  - 1399-543X
UR  - https://doi.org/10.1111/pedi.12924
DO  - doi:10.1111/pedi.12924
SP  - 41
EP  - 231
PY  - 2019
ER  - 

TY  - JOUR
TI  - Oral Presentations
JO  - Journal of Obstetrics and Gynaecology Research
JA  - J. Obstet. Gynaecol. Res.
VL  - 41
IS  - S1
SN  - 1341-8076
UR  - https://doi.org/10.1111/jog.12872
DO  - doi:10.1111/jog.12872
SP  - 6
EP  - 93
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr. Pulmonol.
VL  - 43
IS  - S31
SN  - 8755-6863
UR  - https://doi.org/10.1002/ppul.20939
DO  - doi:10.1002/ppul.20939
SP  - 202
EP  - 462
PY  - 2008
ER  - 

TY  - JOUR
TI  - Table of Contents
JO  - The Brown University Psychopharmacology Update
JA  - Psych. Update
VL  - 16
IS  - 7
SN  - 1068-5308
UR  - https://doi.org/10.1002/pu.20101607
DO  - doi:10.1002/pu.20101607
SP  - 1
EP  - 8
PY  - 2005
AB  - Abstract Experts Explore the Overlap Between OCD and Schizophrenia Groundbreaking Study Finds Earlier than Expected Effects of Antipsychotics St. John's Wort, Ginseng and Warfarin: What's the Story? Is Cognitive Therapy as Effective as Antidepressants? Adjunctive Citalopram Lacks Efficacy for Schizophrenia Patients Adjunctive Eszopiclone with Fluoxetine for MDD and Insomnia New Data for Quetiapine (Seroquel) Ziprasidone (Geodon) for Mania in Bipolar Disorder Lamotrigine Associated with Neutropenia Focalin XR Approved for ADHD FDA Warning on Zoloft Advertising
ER  - 

TY  - JOUR
TI  - Research Abstract Program of the 26th Annual ACVIM Forum San Antonio, TX, June 4 – June 7, 2008
JO  - Journal of Veterinary Internal Medicine
VL  - 22
IS  - 3
SN  - 0891-6640
UR  - https://doi.org/10.1111/j.1939-1676.2008.0103.x
DO  - doi:10.1111/j.1939-1676.2008.0103.x
SP  - 687
EP  - 824
PY  - 2008
ER  - 

TY  - JOUR
TI  - Ventricular Tachycardia
JO  - Journal of Arrhythmia
JA  - J Arrhythmia
VL  - 35
IS  - S1
SN  - 1880-4276
UR  - https://doi.org/10.1002/joa3.12276
DO  - doi:10.1002/joa3.12276
SP  - 542
EP  - 596
PY  - 2019
ER  - 

TY  - JOUR
TI  - HBV Virology and Diagnostics
JO  - Hepatology
JA  - Hepatology
VL  - 58
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.26857
DO  - doi:10.1002/hep.26857
SP  - 705A
EP  - 730A
PY  - 2013
ER  - 

TY  - JOUR
TI  - POSTER SESSIONS
JO  - Allergy
VL  - 62
IS  - s83
SN  - 0105-4538
UR  - https://doi.org/10.1111/j.1398-9995.2007.01407.x
DO  - doi:10.1111/j.1398-9995.2007.01407.x
SP  - 167
EP  - 551
PY  - 2007
ER  - 

TY  - JOUR
TI  - POSTER PRESENTATIONS
JO  - Pediatric Diabetes
VL  - 8
IS  - s7
SN  - 1399-543X
UR  - https://doi.org/10.1111/j.1399-5448.2007.00292.x
DO  - doi:10.1111/j.1399-5448.2007.00292.x
SP  - 24
EP  - 83
PY  - 2007
ER  - 

TY  - JOUR
AU  - Thompson, Philip A.
AU  - Ravandi, Farhad
TI  - How I manage patients with hairy cell leukaemia
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 177
IS  - 4
SN  - 0007-1048
UR  - https://doi.org/10.1111/bjh.14524
DO  - doi:10.1111/bjh.14524
SP  - 543
EP  - 556
KW  - hairy cell leukaemia
KW  - hairy cell leukaemia variant
KW  - purine analogues
KW  - novel therapies
PY  - 2017
AB  - Summary Patients with hairy cell leukaemia (HCL) have highly favourable outcomes after purine analogue therapy. However, most patients subsequently relapse and require re-treatment. A minority of patients develop purine analogue-refractory disease. Targeted therapies have improved outcomes for such patients. Recently, the BRAF V600E mutation was identified in most patients with classical HCL, resulting in constitutive mitogen-activated protein kinase pathway activation; impressive responses are achieved in heavily pre-treated patients with BRAF inhibition. The CD22-targeted immunoconjugate moxetumomab pasudotox and BTK inhibitor ibrutinib also achieve responses in relapsed and refractory patients. HCL variant and the IGHV4-34 molecular variant of HCL lack BRAF mutation and have inferior outcomes with standard purine analogue therapy. The addition of rituximab to purine analogues achieves very high rates of minimal residual disease-negative complete remission and improves outcomes for patients with HCL variant. Given the rarity of HCL, optimal integration of novel therapies into treatment algorithms will require well-designed, collaborative studies.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Internal Medicine Journal
VL  - 38
IS  - s3
SN  - 1444-0903
UR  - https://doi.org/10.1111/j.1445-5994.2008.01728.x
DO  - doi:10.1111/j.1445-5994.2008.01728.x
SP  - A37
EP  - A70
PY  - 2008
ER  - 

TY  - JOUR
TI  - Poster Session 1 Cell and Molecular Biology
JO  - Obesity
VL  - 17
IS  - S2
SN  - 1930-7381
UR  - https://doi.org/10.1038/oby.2009.240
DO  - doi:10.1038/oby.2009.240
SP  - S93
EP  - S165
PY  - 2009
ER  - 
